Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) — Cash Flow Quality Index
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) has a Cash Flow Quality Index of 2.18x as of September 2025. Operating cash flow of CN¥1.73 Billion exceeds net income of CN¥793.91 Million, indicating high earnings quality where cash backs reported profits. Explore 600332 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Cash Flow Quality Index (2000–2025)
Historical Cash Flow Quality Index for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd across 26 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 600332 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (2000–2025)
Year-by-year earnings quality comparison for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd. For live market cap and the full company financial profile, see how much is Guangzhou Baiyunshan Pharmaceutical Hold worth.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.09x | CN¥260.23 Million | CN¥2.98 Billion | ▼ -92.4% |
| 2024 | 1.15x | CN¥3.44 Billion | CN¥3.00 Billion | ▲ +19.1% |
| 2023 | 0.96x | CN¥4.10 Billion | CN¥4.26 Billion | ▼ -41.5% |
| 2022 | 1.65x | CN¥7.00 Billion | CN¥4.25 Billion | ▲ +15.1% |
| 2021 | 1.43x | CN¥5.67 Billion | CN¥3.97 Billion | ▲ +655.2% |
| 2020 | 0.19x | CN¥585.19 Million | CN¥3.09 Billion | ▼ -87.0% |
| 2019 | 1.46x | CN¥5.02 Billion | CN¥3.44 Billion | ▼ -1.1% |
| 2018 | 1.48x | CN¥5.22 Billion | CN¥3.53 Billion | ▲ +70.6% |
| 2017 | 0.87x | CN¥1.83 Billion | CN¥2.12 Billion | ▼ -44.8% |
| 2016 | 1.57x | CN¥2.44 Billion | CN¥1.56 Billion | ▲ +8.7% |
| 2015 | 1.44x | CN¥1.94 Billion | CN¥1.35 Billion | ▼ -0.8% |
| 2014 | 1.45x | CN¥1.76 Billion | CN¥1.21 Billion | ▲ +9.4% |
| 2013 | 1.33x | CN¥1.34 Billion | CN¥1.01 Billion | ▲ +7.2% |
| 2012 | 1.24x | CN¥506.53 Million | CN¥408.33 Million | ▲ +306.7% |
| 2011 | -0.60x | CN¥-180.05 Million | CN¥300.00 Million | ▼ -324.8% |
| 2010 | 0.27x | CN¥73.17 Million | CN¥274.03 Million | ▼ -87.3% |
| 2009 | 2.10x | CN¥439.39 Million | CN¥208.77 Million | ▲ +5830.0% |
| 2008 | 0.04x | CN¥6.10 Million | CN¥171.96 Million | ▼ -96.7% |
| 2007 | 1.09x | CN¥375.74 Million | CN¥344.66 Million | ▲ +571.7% |
| 2006 | 0.16x | CN¥38.88 Million | CN¥239.54 Million | ▼ -78.5% |
| 2005 | 0.75x | CN¥146.32 Million | CN¥194.13 Million | ▼ -75.9% |
| 2004 | 3.13x | CN¥200.54 Million | CN¥64.07 Million | ▲ +6989.5% |
| 2003 | -0.05x | CN¥-6.83 Million | CN¥150.35 Million | ▼ -104.7% |
| 2002 | 0.97x | CN¥169.01 Million | CN¥174.38 Million | ▲ +8.5% |
| 2001 | 0.89x | CN¥140.15 Million | CN¥156.93 Million | ▼ -54.5% |
| 2000 | 1.96x | CN¥286.95 Million | CN¥146.23 Million | — |